Wada, I <br/><br/>
Use of buserelin and low-dose human menopausal gonadotropin for in vitro fertilization in women at risk of ovarian hyperstimulation syndrome.  [electronic resource] 

 -  Journal of assisted reproduction and genetics  Apr 1995 
 - 252-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1058-0468 
<br/><br/><label>Standard No.: </label>10.1007/BF02212927  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Buserelin--adverse effects<br/>Dose-Response Relationship, Drug<br/>Embryo Transfer<br/>Estradiol--blood<br/>Female<br/>Fertilization in Vitro<br/>Gonadotropins--therapeutic use<br/>Humans<br/>Leuprolide--therapeutic use<br/>Menotropins--adverse effects<br/>Menstrual Cycle<br/>Ovarian Hyperstimulation Syndrome--epidemiology<br/>Ovulation Induction<br/>Pregnancy<br/>Pregnancy Outcome<br/>Radioimmunoassay<br/>Risk Factors